BIOPHARMADATA GOVERNANCEINSIGHTS

21 CFR Part 11 in an AI-native workflow

How life-sciences teams keep e-signature auditability while accelerating SOP authoring with AI.

Mar 30, 2026

9 Min Read

21 CFR Part 11 was finalized in 1997. LLMs were not on the radar. But the underlying principles — ALCOA: attributable, legible, contemporaneous, original, accurate — translate cleanly into an AI-native workflow if you architect for them from the start.

The core architectural move

Treat the AI draft as a proposal that a named human steward signs. The signature record captures the prompt, the model version, the retrieval context, and the reviewer identity. The AI never signs; it suggests.

What this unlocks

SOP drafting time drops 50–70% in our deployments
Audit trail is stronger than legacy workflows — every draft, every revision, every prompt is captured
Reviewer fatigue drops because the AI surfaces the diffs that actually need attention
Cross-site harmonization becomes practical because the model enforces template adherence

What goes wrong

Teams that skip the prompt-capture step create a new class of audit finding: ‘the system produced output but cannot reproduce the inputs.’ Auditors hate this and they are right to.

Teams that let the AI sign artifacts directly violate Part 11 §11.200 — electronic signatures must be uniquely linked to an individual. There is no individual behind a model invocation.

Practical implementation notes

Lock model versions per validated workflow. Upgrading the model is a change-control event.
Store the full prompt + context in the signature record. Storage is cheap; audit findings are not.
Require explicit reviewer attestation that they read the diff, not just the final document.
Run periodic blind re-reviews. If reviewers cannot tell which artifacts were AI-drafted, your QA is intact.

Done well, AI authoring is the biggest productivity unlock biopharma quality teams have seen in a decade. Done badly, it is a regulatory time bomb. The difference is in the audit trail.

StewardIQ Team

StewardIQ Team writes for StewardIQ on data governance, AI stewardship, and how regulated enterprises operationalize trust at scale.